Medlyse – From breathing to future diagnostics
Medlyse is developing a new generation of diagnostics that takes advantage of
respiratory gas analysis and AI-based interpretation to detect diseases
quickly and non-invasively. The solution is designed to meet the needs of healthcare
healthcare professionals and support clinical decision-making at an earlier stage than ever before.
at an earlier stage.
The technology under development is aimed at identifying and treating diseases such as lung cancer, asthma, metabolic disorders and other diseases.
metabolic disorders and infections even before symptoms appear. Early
early detection improves prognosis, reduces costs and frees up resources
in a timely manner.
Medlyse is building the tool of the future, bringing accuracy and efficiency to clinical
diagnostics.
